Same Indication

Metformin vs Rituximab

Metformin vs Rituximab: Overview

This comparison examines the pharmacological differences between Metformin and Rituximab.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Metformin — 4-9 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Metformin — C4H11N5.

Molecular Weight: Metformin — 129.1640 g/mol.

Type: Metformin — Small molecule; Rituximab — Antibody.